Lupin has received final approval to market its Tetrabenazine tablets, from the US health regulator. It is used for treating involuntary movements associated with Huntington’s disease....
Lupin has received the establishment investigation report (EIR) for the successful inspection of its Pithampur, Unit 1, from USFDA. The inspection was carried out during July...
Lupin has launched Tydemy tablets, which is suggested to be used by women for contraception. The company in a statement said that, the launch follows the...